Clinical Trial Update: Evaluation of Intraoperative Dexmedetomidine Use in Patients Undergoing Surgical Aortic Valve Replacement [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intraoperative dexmedetomidine use in patients undergoing surgical aortic valve replacement has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Stenosis
• Systemic Inflammatory Response Syndrome

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: University Hospital Dubrava | Conditions: Systemic Inflammatory Response, Aortic Valve Stenosis | Phase 3 | Status: COMPLETED